Antibody engineers seek optimal drug targeting TIGIT checkpoint

被引：0
|
作者：
Elie Dolgin
机构：
来源：
Nature Biotechnology | 2020年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Four antibodies are already in trials to test efficacy against the emerging checkpoint molecule TIGIT, but debate swirls around the importance of Fc binding for drug action.
引用
收藏
页码：1007 / 1009
页数：2
相关论文
共 50 条
  • [21] A method for detecting antibody internalization in drug targeting
    Jaime, J
    Pagé, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (04) : 835 - 839
  • [22] Targeting the tumor vasculature with antibody drug conjugates
    Hooper, Andrea T.
    Chang, Chao-Pei Betty
    Marquette, Kimberly
    Golas, Jonathon
    Lucas, Justin
    Nichols, Timothy
    Lucas, Judy
    Maria, Gavriil
    Rosfjord, Edward
    Xavier, Anton
    Scott, Nathan
    Jain, Sadhana
    Cao, Wei
    Leal, Mauricio
    Maderna, Andreas
    Guffroy, Magali
    Zheng, Xiang
    Tchistiakova, Lioudmila
    Loganzo, Frank
    Gerber, Hans-Peter
    May, Chad
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors
    Guo, Yizhen
    Remaily, Bryan C.
    Thomas, Justin
    Kim, Kyeongmin
    Kulp, Samuel K.
    Mace, Thomas A.
    Ganesan, Latha P.
    Owen, Dwight H.
    Coss, Christopher C.
    Phelps, Mitch A.
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 942 - 958
  • [24] DRUG TARGETING WITH MONOCLONAL-ANTIBODY CONJUGATES OF CHEMOTHERAPEUTIC DRUG HYDRAZIDES
    HEINDEL, ND
    ZHAO, HR
    LACEY, CJ
    SHABSOUG, B
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 71 - MEDI
  • [25] Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug
    Petrilli, Raquel
    Pinheiro, Daniel Pascoalino
    Evangelista de Oliveira, Fatima de Cassia
    Galvao, Gabriela Favero
    Alves Marques, Lana Grasiela
    Vianna Lopez, Renata Fonseca
    Pessoa, Claudia
    Eloy, Josimar O.
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (13) : 2485 - 2520
  • [26] Development of a Fundamental Technology to Seek Drug Targets, and Its Application to Cancer Targeting Therapy
    Nagano, Kazuya
    Higashisaka, Kazuma
    Tsunoda, Shin-ichi
    Tsutsumi, Yasuo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (07): : 903 - 909
  • [27] Tumor targeting with antimitotic monoclonal antibody drug conjugates.
    Senter, Peter
    CANCER RESEARCH, 2013, 73 (08)
  • [28] Targeting cancer with antibody-drug conjugates: Promises and challenges
    Dean, Alexis Q.
    Luo, Shen
    Twomey, Julianne D.
    Zhang, Baolin
    MABS, 2021, 13 (01)
  • [29] Targeting cancer with antibody-drug conjugates: Promises and challenges
    Dean, Alexis
    Twomey, Julianne
    Zhang, Baolin
    CANCER RESEARCH, 2020, 80 (16)
  • [30] Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade
    Patil, Namrata S.
    Srivats, Shyam
    Choi, Yoonha
    Guan, Xiangnan
    Nabet, Barzin
    McGinnis, Lisa
    Chiang, Eugene
    Dunkle, Alexis
    O'Gorman, Bill
    Chang, Patrick S.
    Hu, Ruozhen
    Silva, John
    Han, Joy
    Au-Yeung, Amelia
    Takahashi, Chikara
    Molden, Nandini
    Daggumati, Pallavi
    Connolly, Wendy
    Johnson, Melissa
    Abreu, Delvys Rodriguez
    Cho, Byoung Chul
    Italiano, Antoine
    Gil-Bazo, Ignacio
    Felip, Enriqueta
    Mellman, Ira
    Meng, Raymond
    Mariathasan, Sanjeev
    Johnston, Robert
    Shames, David S.
    CANCER RESEARCH, 2023, 83 (07)
12345